Since acute pulmonary embolism (PE) remains one of the leading causes of cardiovascular morbidity and mortality, the increased attention to risk prediction is well deserved [1]. Timely and accurate risk stratification of acute PE is critical to decide the site of care and to implement therapies that may help improve patient outcomes [2].
